TY - JOUR
T1 - Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells
AU - Yasmin, Tania
AU - Takahashi-Yanaga, Fumi
AU - Mori, Jun
AU - Miwa, Yoshikazu
AU - Hirata, Masato
AU - Watanabe, Yutaka
AU - Morimoto, Sachio
AU - Sasaguri, Toshiyuki
N1 - Funding Information:
We thank Drs. A. Arnold, R. Pestell (Lombardi Comprehensive Cancer Center, Georgetown University), O. Tetsu, and F. McCormick (University of California, San Francisco) for kindly providing wild-type and mutant cyclin D1 pGL3 basic luciferase reporter plasmids. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (a Grant-in-Aid for Scientific Research).
PY - 2005/12/16
Y1 - 2005/12/16
N2 - To determine the mechanism by which differentiation-inducing factor-1 (DIF-1), a morphogen of Dictyostelium discoideum, inhibits tumor cell proliferation, we examined the effect of DIF-1 on the gene expression of cyclin D1. DIF-1 strongly reduced the expression of cyclin D1 mRNA and correspondingly decreased the amount of β-catenin in HeLa cells and squamous cell carcinoma cells. DIF-1 activated glycogen synthase kinase-3β (GSK-3β) and inhibition of GSK-3β attenuated the DIF-1-induced β-catenin degradation, indicating the involvement of GSK-3β in this effect. Moreover, DIF-1 reduced the activities of T-cell factor (TCF)/lymphoid enhancer factor (LEF) reporter plasmid and a reporter gene driven by the human cyclin D1 promoter. Eliminating the TCF/LEF consensus site from the cyclin D1 promoter diminished the effect of DIF-1. These results suggest that DIF-1 inhibits Wnt/β-catenin signaling, resulting in the suppression of cyclin D1 promoter activity.
AB - To determine the mechanism by which differentiation-inducing factor-1 (DIF-1), a morphogen of Dictyostelium discoideum, inhibits tumor cell proliferation, we examined the effect of DIF-1 on the gene expression of cyclin D1. DIF-1 strongly reduced the expression of cyclin D1 mRNA and correspondingly decreased the amount of β-catenin in HeLa cells and squamous cell carcinoma cells. DIF-1 activated glycogen synthase kinase-3β (GSK-3β) and inhibition of GSK-3β attenuated the DIF-1-induced β-catenin degradation, indicating the involvement of GSK-3β in this effect. Moreover, DIF-1 reduced the activities of T-cell factor (TCF)/lymphoid enhancer factor (LEF) reporter plasmid and a reporter gene driven by the human cyclin D1 promoter. Eliminating the TCF/LEF consensus site from the cyclin D1 promoter diminished the effect of DIF-1. These results suggest that DIF-1 inhibits Wnt/β-catenin signaling, resulting in the suppression of cyclin D1 promoter activity.
UR - http://www.scopus.com/inward/record.url?scp=27744470248&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27744470248&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2005.10.018
DO - 10.1016/j.bbrc.2005.10.018
M3 - Article
C2 - 16243295
AN - SCOPUS:27744470248
VL - 338
SP - 903
EP - 909
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
SN - 0006-291X
IS - 2
ER -